Baxter S.A.

Baxter S.A.

Baxter S.A. deployed a Wonderware software solution to upgrade its patient care product manufacturing systems to streamline operations as well as meet U.S. and EMEA regulations.

  • Serge Bassem, CEO

    To be successful, strategic projects require excellent collaboration between the customer, the software vendor and integrator. By establishing the automation framework, Wonderware software solutions enabled our project teams to focus on productivity targets.

  • Goals

    • Increasing production capacity while significantly reducing manufacturing throughput time was a top priority for Baxter
    • The new automation system needed to assist Baxter in achieving U.S. Food and Drug Administration (FDA) 21 CFR Part 11 compliance regulations
  • Challenges

    • The automation system selected for the new Baxter production line had to be fully compatible with Baxter’s existing architecture and systems
    • The company required that the new system integrate Profibus-connected smart sensors into the new manufacturing line process
    • Production management had to be centralized and include reporting, analysis, traceability and performance monitoring to adhere to FDA 21 CFR Part 11 regulations as well as European compliance standards
  • Results

    • The implementation of the new Wonderware system doubled the manufacturing facility’s productivity
    • Baxter’s manufacturing processes are now fully traceable and meet all FDA and European regulations
    • Wonderware System Platform has enabled the BiiON engineers to create roughly 35 reusable generic objects, which are stored in a central library